FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:215-216 January 20, 2000 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone are known side effects of selective serotonin-reuptake inhibitors such as fluoxetine and sertraline^1,2 and the inhibitor of serotonin and norepinephrine reuptake venlafaxine.³ We describe the occurrence of hyponatremia in a patient treated with reboxetine, a new antidepressant drug that is a norepinephrine-reuptake inhibitor. The patient was a 72-year-old man who was hospitalized for rehabilitation for mild left hemiparesis caused by a stroke three months earlier and for treatment of severe depressive symptoms, including depressed mood, feelings of worthlessness, and recurrent thoughts of death that had begun after . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.